• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定左心室辅助装置感染的病原体微生物,为噬菌体治疗的发展提供指导。

Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy.

机构信息

Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, Texas.

Department of Surgery, Baylor College of Medicine, Houston, Texas.

出版信息

J Surg Res. 2022 Mar;271:73-81. doi: 10.1016/j.jss.2021.10.010. Epub 2021 Nov 27.

DOI:10.1016/j.jss.2021.10.010
PMID:34847492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9125500/
Abstract

BACKGROUND

As more left ventricular-assist devices (LVADs) are implanted, multidrug-resistant LVAD infections are becoming increasingly common, partly due to bacterial biofilm production. To aid in developing bacteriophage therapy for LVAD infections, we have identified the most common bacterial pathogens that cause LVAD driveline infections (DLIs) in our heart transplant referral center.

MATERIALS AND METHODS

We studied a retrospective cohort of patients who received LVADs from November 2003 to August 2017 to identify the common causative organisms of LVAD infection. We also studied a prospective cohort of patients diagnosed with DLIs from October 2018 to May 2019 to collect bacterial strains from DLIs for developing bacteriophages to lyse causative pathogens. LVAD infections were classified as DLI, bacteremia, and pump/device infections in the retrospective cohort.

RESULTS

In the retrospective cohort of 582 patients, 186 (32.0%) developed an LVAD infection, with 372 microbial isolates identified. In the prospective cohort, 96 bacterial strains were isolated from 54 DLIs. The microorganisms causing DLIs were similar in the two cohorts; the most common isolate was Staphylococcus aureus. We identified 6 prospective S. aureus strains capable of biofilm formation. We developed 3 bacteriophages that were able to lyse 5 of 6 of the biofilm-forming S. aureus strains.

CONCLUSIONS

Similar pathogens caused LVAD DLIs in our retrospective and prospective cohorts, indicating our bacterial strain bank will be representative of future DLIs. Our banked bacterial strains will be useful in developing phage cocktails that can lyse ≥80% of the bacteria causing LVAD infections at our institution.

摘要

背景

随着越来越多的左心室辅助装置(LVAD)被植入,多药耐药性 LVAD 感染变得越来越常见,部分原因是细菌生物膜的产生。为了帮助开发针对 LVAD 感染的噬菌体疗法,我们已经确定了我们心脏移植转诊中心导致 LVAD 驱动线感染(DLIs)的最常见细菌病原体。

材料和方法

我们研究了一组接受 LVAD 的回顾性队列患者,以确定 LVAD 感染的常见病原体。我们还研究了一组从 2018 年 10 月至 2019 年 5 月被诊断为 DLI 的前瞻性队列患者,以收集 DLI 中的细菌株,用于开发裂解致病病原体的噬菌体。在回顾性队列中,LVAD 感染分为 DLI、菌血症和泵/装置感染。

结果

在 582 例患者的回顾性队列中,186 例(32.0%)发生 LVAD 感染,共鉴定出 372 株微生物分离株。在前瞻性队列中,从 54 例 DLI 中分离出 96 株细菌株。两个队列中导致 DLI 的微生物相似,最常见的分离株是金黄色葡萄球菌。我们鉴定出 6 株能够形成生物膜的潜在金黄色葡萄球菌菌株。我们开发了 3 种噬菌体,能够裂解 5 株 6 株形成生物膜的金黄色葡萄球菌菌株。

结论

在我们的回顾性和前瞻性队列中,导致 LVAD DLI 的病原体相似,这表明我们的细菌株库将代表未来的 DLI。我们的细菌株库将有助于开发噬菌体鸡尾酒,能够裂解我们机构中导致 80%以上 LVAD 感染的细菌。

相似文献

1
Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy.鉴定左心室辅助装置感染的病原体微生物,为噬菌体治疗的发展提供指导。
J Surg Res. 2022 Mar;271:73-81. doi: 10.1016/j.jss.2021.10.010. Epub 2021 Nov 27.
2
Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study.在使用心室辅助装置的患者中,细菌病原体在动力线出口部位的动力学:一项前瞻性、观察性、单中心队列研究。
J Heart Lung Transplant. 2023 Oct;42(10):1445-1454. doi: 10.1016/j.healun.2023.05.016. Epub 2023 May 26.
3
Driveline Infection in Patients With Left Ventricular Assist Devices Implanted as Destination Therapy.左心室辅助装置作为终末期治疗植入患者的输线型感染。
Transplant Proc. 2024 May;56(4):860-863. doi: 10.1016/j.transproceed.2024.03.029. Epub 2024 May 11.
4
Driveline infections in left ventricular assist devices-Incidence, epidemiology, and staging proposal.左心室辅助装置中的传动系统感染:发生率、流行病学和分期建议。
Artif Organs. 2024 Jan;48(1):83-90. doi: 10.1111/aor.14647. Epub 2023 Sep 18.
5
Left ventricle assist devices and driveline's infection incidence: a single-centre experience.左心室辅助装置及驱动线感染发生率:单中心经验
J Artif Organs. 2018 Mar;21(1):52-60. doi: 10.1007/s10047-017-0997-y. Epub 2017 Oct 7.
6
Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: A single-center descriptive experience.慢性抗菌抑制疗法治疗左心室辅助装置导线感染的疗效和安全性:单中心描述性经验。
Transpl Infect Dis. 2020 Oct;22(5):e13379. doi: 10.1111/tid.13379. Epub 2020 Jul 6.
7
The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center.慢性抑制性抗生素治疗在左心室辅助装置浅表驱动线感染复发中的作用:来自三级医疗中心的回顾性队列研究。
Transpl Infect Dis. 2021 Aug;23(4):e13686. doi: 10.1111/tid.13686. Epub 2021 Jul 20.
8
Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients.连续血流心室辅助装置受者中驱动线感染的演变和影响。
J Heart Lung Transplant. 2014 Nov;33(11):1164-72. doi: 10.1016/j.healun.2014.05.011. Epub 2014 Jun 5.
9
Left ventricular assist device-related infections: a multicentric study.左心室辅助装置相关感染:一项多中心研究。
Clin Microbiol Infect. 2017 Oct;23(10):748-751. doi: 10.1016/j.cmi.2017.03.008. Epub 2017 Mar 18.
10
Clinical manifestations and management of left ventricular assist device-associated infections.左心室辅助装置相关感染的临床表现和处理。
Clin Infect Dis. 2013 Nov;57(10):1438-48. doi: 10.1093/cid/cit536. Epub 2013 Aug 13.

引用本文的文献

1
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.一项 12 例扩展准入定制噬菌体治疗的回顾性观察性研究:生产、特征和临床结果。
Clin Infect Dis. 2023 Oct 13;77(8):1079-1091. doi: 10.1093/cid/ciad335.

本文引用的文献

1
Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States.从美国一家中心连续治疗多药耐药细菌感染的首例10例静脉注射噬菌体疗法中吸取的经验教训。
Open Forum Infect Dis. 2020 Aug 27;7(9):ofaa389. doi: 10.1093/ofid/ofaa389. eCollection 2020 Sep.
2
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.噬菌体-抗生素协同作用是由独特的抗菌作用机制和化学计量比组合驱动的。
mBio. 2020 Aug 4;11(4):e01462-20. doi: 10.1128/mBio.01462-20.
3
Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity.
噬菌体疗法治疗危及肢体的人工膝关节耐甲氧西林肺炎克雷伯菌感染:病例报告及抗生物膜活性的体外特征。
Clin Infect Dis. 2021 Jul 1;73(1):e144-e151. doi: 10.1093/cid/ciaa705.
4
Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk Patients.定制抗菌药物与噬菌体(Φ)研究创新实验室:为最脆弱的高危患者提供个性化传染病医学。
Phage (New Rochelle). 2020 Jun 1;1(2):66-74. doi: 10.1089/phage.2020.0007. Epub 2020 Jun 16.
5
In Full Flow: Left Ventricular Assist Device Infections in the Modern Era.全面解析:现代左心室辅助装置感染
Open Forum Infect Dis. 2020 Apr 17;7(5):ofaa124. doi: 10.1093/ofid/ofaa124. eCollection 2020 May.
6
Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery.用于心胸外科相关严重感染的噬菌体疗法
Antibiotics (Basel). 2020 May 5;9(5):232. doi: 10.3390/antibiotics9050232.
7
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.治疗金黄色葡萄球菌血流感染和心内膜炎的药物。
J Clin Invest. 2020 Jul 1;130(7):3750-3760. doi: 10.1172/JCI136577.
8
Treatment of chronic left ventricular assist device infection with local application of bacteriophages.局部应用噬菌体治疗慢性左心室辅助装置感染
Eur J Cardiothorac Surg. 2020 May 1;57(5):1003-1004. doi: 10.1093/ejcts/ezz295.
9
Biofilm formation and migration on ventricular assist device drivelines.生物膜在心室辅助装置驱动线上的形成和迁移。
J Thorac Cardiovasc Surg. 2020 Feb;159(2):491-502.e2. doi: 10.1016/j.jtcvs.2019.02.088. Epub 2019 Mar 6.
10
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.全磁悬浮左心室辅助装置 - 最终报告。
N Engl J Med. 2019 Apr 25;380(17):1618-1627. doi: 10.1056/NEJMoa1900486. Epub 2019 Mar 17.